Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7)

Yu Ching Wen; Van Thi Ngoc Tram; Wei Hao Chen; Chien Hsiu Li; Hsiu Lien Yeh; Phan Vu Thuy Dung; Kuo Ching Jiang; Han Ru Li; Jiaoti Huang; Michael Hsiao; Wei Yu Chen; Yen Nien Liu

doi:10.1038/s41419-023-06363-1

Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7)

Yu Ching Wen, Van Thi Ngoc Tram, Wei Hao Chen, Chien Hsiu Li, Hsiu Lien Yeh, Phan Vu Thuy Dung, Kuo Ching Jiang, Han Ru Li, Jiaoti Huang, Michael Hsiao, Wei Yu Chen, Yen Nien Liu

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

摘要

Correction to: Cell Death and Disease, published online 04 May 2023 In this article, the author Yen-Nien Liu has been affiliated with: 4International PhD Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan 10TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. it should read: 5Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan. 10TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. The original article has been corrected.

原文	英語
文章編號	92
期刊	Cell Death and Disease
卷	15
發行號	1
DOIs	https://doi.org/10.1038/s41419-023-06363-1
出版狀態	已發佈 - 1月 2024

ASJC Scopus subject areas

免疫學
細胞與分子神經科學
細胞生物學
癌症研究

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.1038/s41419-023-06363-1

其它文件與鏈接

引用此

Wen, Y. C., Tram, V. T. N., Chen, W. H., Li, C. H., Yeh, H. L., Thuy Dung, P. V., Jiang, K. C., Li, H. R., Huang, J., Hsiao, M., Chen, W. Y., & Liu, Y. N. (2024). Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7). Cell Death and Disease, 15(1), 文章 92. https://doi.org/10.1038/s41419-023-06363-1

Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7). / Wen, Yu Ching; Tram, Van Thi Ngoc; Chen, Wei Hao 等.
於: Cell Death and Disease, 卷 15, 編號 1, 92, 01.2024.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

Wen, YC, Tram, VTN, Chen, WH, Li, CH, Yeh, HL, Thuy Dung, PV, Jiang, KC, Li, HR, Huang, J, Hsiao, M, Chen, WY & Liu, YN 2024, 'Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7)', Cell Death and Disease, 卷 15, 編號 1, 92. https://doi.org/10.1038/s41419-023-06363-1

@article{938ae9cd59604611b6595fe004b64078,

title = "Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7)",

abstract = "Correction to: Cell Death and Disease, published online 04 May 2023 In this article, the author Yen-Nien Liu has been affiliated with: 4International PhD Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan 10TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. it should read: 5Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan. 10TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. The original article has been corrected.",

author = "Wen, {Yu Ching} and Tram, {Van Thi Ngoc} and Chen, {Wei Hao} and Li, {Chien Hsiu} and Yeh, {Hsiu Lien} and {Thuy Dung}, {Phan Vu} and Jiang, {Kuo Ching} and Li, {Han Ru} and Jiaoti Huang and Michael Hsiao and Chen, {Wei Yu} and Liu, {Yen Nien}",

note = "Publisher Copyright: {\textcopyright} 2024, The Author(s).",

year = "2024",

month = jan,

doi = "10.1038/s41419-023-06363-1",

language = "English",

volume = "15",

journal = "Cell Death and Disease",

issn = "2041-4889",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Correction

T2 - CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7)

AU - Wen, Yu Ching

AU - Tram, Van Thi Ngoc

AU - Chen, Wei Hao

AU - Li, Chien Hsiu

AU - Yeh, Hsiu Lien

AU - Thuy Dung, Phan Vu

AU - Jiang, Kuo Ching

AU - Li, Han Ru

AU - Huang, Jiaoti

AU - Hsiao, Michael

AU - Chen, Wei Yu

AU - Liu, Yen Nien

PY - 2024/1

Y1 - 2024/1

N2 - Correction to: Cell Death and Disease, published online 04 May 2023 In this article, the author Yen-Nien Liu has been affiliated with: 4International PhD Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan 10TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. it should read: 5Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan. 10TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. The original article has been corrected.

AB - Correction to: Cell Death and Disease, published online 04 May 2023 In this article, the author Yen-Nien Liu has been affiliated with: 4International PhD Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan 10TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. it should read: 5Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan. 10TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85183396446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85183396446&partnerID=8YFLogxK

U2 - 10.1038/s41419-023-06363-1

DO - 10.1038/s41419-023-06363-1

M3 - Comment/debate

C2 - 38287005

AN - SCOPUS:85183396446

SN - 2041-4889

VL - 15

JO - Cell Death and Disease

JF - Cell Death and Disease

IS - 1

M1 - 92

ER -

Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7)

摘要

ASJC Scopus subject areas

UN SDG

存取文件

其它文件與鏈接

指紋

引用此